21.19

3.11% 0.64

After Hours: 21.16 -0.03 -0.14%

First Tracks Biotherapeutics Inc (TRAX)

Overview News Price History Discussions Forecast

First Tracks Biotherapeutics Inc stock is traded at $21.19, with a volume of 342.58K. It is up +3.11% in the last 24 hours and up +0.00% over the past month. First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

Previous Close:

$20.55

Open:

$20.59

24h Volume:

342.58K

Relative Volume:

3.26

Market Cap:

$736.33M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+5.69%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$20.00

$22.20

1-Week Range:

$19.65

$25.58

52-Week Range:

$16.59

$25.58

First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile

Name

First Tracks Biotherapeutics Inc

Sector

Healthcare (1106)

Industry

Biotechnology (615)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

TRAX's Discussions on Twitter

Compare TRAX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TRAX First Tracks Biotherapeutics Inc	21.19	714.09M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	424.36	109.34B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	74.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	50.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	39.78B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.02B	5.36B	287.73M	924.18M	2.5229

First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-24-26	Initiated	Leerink Partners	Outperform
Apr-24-26	Initiated	Wedbush	Outperform
Apr-23-26	Initiated	JP Morgan	Overweight
Apr-22-26	Initiated	Barclays	Overweight
Apr-21-26	Initiated	UBS	Buy

First Tracks Biotherapeutics Inc Stock (TRAX) Latest News

12:06 PM

This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm

12:06 PM

May 04, 2026

First Tracks Price Target Announced at $54.00/Share by Piper Sandler - Moomoo

May 04, 2026

First Tracks Initiated at Overweight by Piper Sandler - Moomoo

May 04, 2026

This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations F - Benzinga

May 04, 2026

Piper Sandler initiates First Tracks stock with overweight rating By Investing.com - Investing.com Nigeria

May 04, 2026

May 03, 2026

Net income of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

May 03, 2026

May 01, 2026